Our Deals

Dec 2024

has received a strategic growth investment from

Dec 2024

Private Placement of Common Stock

$45,396,505

These securities have been previously sold. This announcement appears as a matter of record only.

Nov 2024

Series Seed Preferred Stock Financing

Oct 2024

has merged with

Aug 2024

has acquired

Aug 2024

has been acquired by

Aug 2024

Private Placement of Common Stock, Pre-Funded Warrants, and Warrants

$100,000,000

These securities have been previously sold. This announcement appears as a matter of record only.

Aug 2024

License and Collaboration Agreement with

Novartis

Aug 2024

merged its subsidiary with

to create

$650,000,000

Jul 2024

has merged with

Jul 2024

Compound Discovery Agreement with

Jun 2024

has been acquired by

$100,000,000

May 2024

Completes Equity Sale of

$15,000,000

May 2024

Private Placement of Common Stock

$12,000,000

These securities have been previously sold. This announcement appears as a matter of record only.

May 2024

has been acquired by

Apr 2024

has been acquired by

Apr 2024

Registered Direct Offering of Common Stock and Warrants

$15,000,000

These securities have been previously sold. This announcement appears as a matter of record only.

Mar 2024

Series A-2 Milestone Financing

$6,425,000

Mar 2024

has acquired

AlmataBio, Inc. 

and completed a

Private Placement Financing of up to $185 Million 

These securities have been previously sold. This announcement appears as a matter of record only.

Mar 2024

has been acquired by

Mar 2024

Convertible Promissory Note Financing

$4,000,000

Feb 2024

Private Placement of Preferred Stock

$17,923,000

These securities have been previously sold. This announcement appears as a matter of record only.

Feb 2024

Public Offering of Common Stock and Warrants

$9,040,000

These securities have been previously sold. This announcement appears as a matter of record only.

Jan 2024

has acquired

Jan 2024

has been acquired by

Dec 2023

Offering of Common Stock

$4,000,000

Nov 2023

has been acquired by

Nov 2023

has been acquired by

Nov 2023

Series Seed-1 Preferred Stock Financing

$4,650,000

Nov 2023

Sale of Common Stock

$8,000,000

These securities have been
previously sold. This announcement
appears as a matter of record only.